Not recruiting
Investigational
Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients
Investigational
- Substances:Telitacicept
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Telitacicept
Find therapies in clinical trials near you – page 225
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
2 699 trials match your criteria
Not recruiting
Nephropathy
Not recruitingInvestigational
Study on the Effects of Povetacicept for Adults with IgA Nephropathy
Investigational
- Disease:Nephropathy
- Substances:Povetacicept
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Povetacicept
Not recruiting
Diabetic retinal oedema
Not recruitingRegistered drugNo placebo
Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
Registered drugNo placebo
- Disease:Diabetic retinal oedema
- Substances:Eye103Fluorescein Sodium+1
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Eye103
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drug
Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
Registered drug
- Disease:Non-small cell lung cancer
- Substances:Durvalumab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Durvalumab
Not recruiting
Colitis ulcerative
Not recruitingInvestigationalNo placebo
Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
InvestigationalNo placebo
- Disease:Colitis ulcerative
- Substances:Morf-057
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Morf-057
Not recruiting
Hypertrophic cardiomyopathy
Not recruitingRegistered drug
Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy
Registered drug
- Disease:Hypertrophic cardiomyopathy
- Substances:Empagliflozin
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Empagliflozin
Not recruiting
Skin cancer+1
Not recruitingInvestigationalNo placebo
Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers
InvestigationalNo placebo
- Disease:Skin cancerBasal cell carcinoma
- Substances:Balstilimab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Balstilimab
Not recruiting
Colitis ulcerative
Not recruitingInvestigational
Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
Investigational
- Disease:Colitis ulcerative
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
Not recruiting
Colitis ulcerative
Not recruitingInvestigational
Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
Investigational
- Disease:Colitis ulcerative
- Substances:Ro7790121
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Ro7790121
Not recruiting
Non-small cell lung cancer+1
Not recruitingRegistered drug
Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Registered drug
- Disease:Non-small cell lung cancerNon-small cell lung cancer metastatic
- Substances:AtezolizumabTiragolumab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
Status unknown
Chronic spontaneous urticaria
Status unknownRegistered drug
Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines
Registered drug
Countries:Poland
Poland- Participants:0–17 years
- Substances:Remibrutinib